|Start of new Phase 1 imaging study:
ABX-CRO has received final, positive EC vote for a new Phase 1 imaging study with Healthy Volunteers (Gesunde Probanden) and patients with Huntington's Disease. The study will take place in co-operation with 'Universität Leipzig, Klinik und Poliklinik für Nuklearmedizin' and 'Arzneimittelforschung Leipzig GmbH'.
Zentralklinik Bad Berka acquires QDOSE for internal dosimetry
QDOSE is the comprehensive software suite for internal dosimetry. Designed by practitioners, QDOSE offers one-stop solutions for daily routine use or scientific investigation. It offers multiple workflows for planar, hybrid, volumetric, or SIRT dosimetry to speed up and simplify processes using highest state of the art methodologies and algorithms.
For more information visit www.quantitativedose.com